https://www.selleckchem.com/pr....oducts/cobimetinib-g
in household ventilation, cooking technologies as well as in child handling and in the peculiar local extra indoor burning practices.BACKGROUND Treatment resistance is a major clinical challenge of diffuse large B-cell lymphoma (DLBCL) where approximately 40% of the patients have refractory disease or relapse. Since DLBCL is characterized by great clinical and molecular heterogeneity, the purpose of the present study was to investigate whether miRNAs associated to single drug components of R-CHOP can improve robustne
Like
Comment
Share
